Abstract:Neuroimage measures from magnetic resonance (MR) imaging, such as cortical thickness, have been playing an increasingly important role in searching for biomarkers of Alzheimer's disease (AD). Recent studies show that, AD, mild cognitive impairment (MCI) and normal control (NC) can be distinguished with relatively high accuracy using the baseline cortical thickness. With the increasing availability of large longitudinal datasets, it also becomes possible to study the longitudinal changes of cortical thickness and their correlation with the development of pathology in AD. In this study, the longitudinal cortical thickness changes of 152 subjects from 4 clinical groups (AD, NC, Progressive-MCI and Stable-MCI) selected from Alzheimer's Disease Neuroimaging Initiative (ADNI) are measured by our recently developed 4 D (spatial+temporal) thickness measuring algorithm. It is found that the 4 clinical groups demonstrate very similar spatial distribution of grey matter (GM) loss on cortex. To fully utilize the longitudinal information and better discriminate the subjects from 4 groups, especially between Stable-MCI and Progressive-MCI, 3 different categories of features are extracted for each subject, i.e., (1) static cortical thickness measures computed from the baseline and endline, (2) cortex thinning dynamics, such as the thinning speed (mm/year) and the thinning ratio (endline/baseline), and (3) network features computed from the brain network constructed based on the correlation between the longitudinal thickness changes of different regions of interest (ROIs). By combining the complementary information provided by features from the 3 categories, 2 classifiers are trained to diagnose AD and to predict the conversion to AD in MCI subjects, respectively. In the leave-one-out cross-validation, the proposed method can distinguish AD patients from NC at an accuracy of 96.1%, and can detect 81.7% (AUC = 0.875) of the MCI converters 6 months ahead of their conversions to AD. Also, by analyzing the brain network built via longitudinal cortical thickness changes, a significant decrease (p < 0.02) of the network clustering coefficient (associated with the development of AD pathology) is found in the Progressive-MCI group, which indicates the degenerated wiring efficiency of the brain network due to AD. More interestingly, the decreasing of network clustering coefficient of the olfactory cortex region was also found in the AD patients, which suggests olfactory dysfunction. Although the smell identification test is not performed in ADNI, this finding is consistent with other AD-related olfactory studies.

Longitudinal Relationship Between Brain Atrophy Patterns, Cognitive Decline, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease Explored by Orthonormal Projective Non-Negative Matrix Factorization

DIFFERENTIAL GREY AND WHITE MATTER MICROSTRUCTURAL ABNORMALITIES IN EARLY AND LATE-ONSET ALZHEIMER’S DISEASE AND MILD COGNITIVE IMPAIRMENT

Distinct Atrophy Pattern of Hippocampal Subfields in Patients with Progressive and Stable Mild Cognitive Impairment: A Longitudinal MRI Study

IC-03-06: Six Month MRI Gray Matter Declines in Alzheimer's Dementia Evaluated by Voxel-Based Morphometry with Multivariate Network Analysis: Preliminary Findings from the ADNI Study

P1‐216: Six Month MRI Gray Matter Declines in Alzheimer's Dementia Evaluated by Voxel‐based Morphometry with Multivariate Network Analysis: Preliminary Findings from the Alzheimer's Disease Neuroimaging Initiative

Discriminant Analysis of Longitudinal Cortical Thickness Changes in Alzheimer's Disease Using Dynamic and Network Features

Longitudinal Trajectory of Amyloid-related Hippocampal Subfield Atrophy in Nondemented Elderly.

Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer’s Disease Continuum

DeepAtrophy: Teaching a Neural Network to Differentiate Progressive Changes from Noise on Longitudinal MRI in Alzheimer's Disease

Whole Brain Atrophy Based on Iterative Principal Component Analysis and MRI Techniques in the Study of Alzheimer's Disease

Longitudinal Volumetric Study for the Progression of Alzheimer's Disease from Structural MRI

IC–P–025: Regional Network Pattern of MRI Gray Matter Volume in Alzheimer's Dementia

Longitudinal Changes in Surface Based Brain Morphometry Measures in Amnestic Mild Cognitive Impairment and Alzheimer's Disease

IC‐P‐089: Can Three Months MRI Volumetric Parameters Help the Prediction of Progression from MCI to Alzheimer's Disease? Results from the Addneuromed Study

Baseline Multimodal Imaging to Predict Longitudinal Clinical Decline in Atypical Alzheimer's Disease

MICROGLIAL ACTIVATION AND TAU BURDEN PREDICT COGNITIVE DECLINE IN ALZHEIMER’S DISEASE

Analyzing the Spatiotemporal Interaction and Propagation of ATN Biomarkers in Alzheimer's Disease using Longitudinal Neuroimaging Data

Disentangling the heterogeneity of brain atrophy in Alzheimer’s Disease

Predicting Brain Amyloid Using Multivariate Morphometry Statistics, Sparse Coding, and Correntropy: Validation in 1,101 Individuals From the ADNI and OASIS Databases

P-020: Regional Gray Matter Reductions in Alzheimer’s Dementia and Amnestic Mild Cognitive Impairment: Preliminary Findings from the Alzheimer’s Disease Neuroimaging Initiative Using Voxel-Based Morphometry

Disentangling Alzheimer's disease neurodegeneration from typical brain aging using machine learning